GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

Rating:
Hold ARIA

Ariad Pharmaceuticals, Inc. (ARIA) rated Hold by Argus

Posted on: Thursday,  Mar 18, 2010  8:25 AM ET by Argus

Ariad Pharmaceuticals, Inc.
(NASDAQ: ARIA) rated Hold by Argus.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/14/2013 8:25 AM Sell
None
4.07
as of 8/27/2015
1 Week up  8.03 %
1 Month up  21.48 %
3 Months up  21.66 %
1 YTD down  -2.34 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/18/2010 8:25 AM Hold
None
3.67

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy